Device Trial Radar · NCT07631715
Withings Hypertension Notification Retrospective Study
Last checked: Nov 20, 2026Latest source record: Jul 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
2,500
Planned (sponsor's estimate)
Start
Mar 1, 2026
Primary completion
Jul 2026
Study completion Jul 2026
Sponsor
- Lead sponsor
- WithingsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 8, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This retrospective, non-interventional clinical investigation evaluates the diagnostic performance of the Withings Hypertension Notification Feature (HTNF), a software-only medical device (SaMD) that analyzes demographic, anthropometric, and physiological parameters collected by Withings connected smart scales to identify patterns suggestive of hypertension. Ground-truth blood pressure measurements are obtained concurrently from Withings connected blood pressure monitors.
Conditions
- Hypertension
Interventions
Withings Blood Pressure Monitor (reference)Device
Ground-truth weekly average systolic and diastolic blood pressure measurements obtained from Withings connected blood pressure monitors (BPM \[WPM02\], BPM+ \[WPM03\], BPM Core \[WPM04\], BPM Connect \[WPM05\]), validated as non-invasive oscillometric blood pressure monitors per ISO 81060-2:2018. Minimum 7 measurements per user-week required.
Withings Hypertension Notification Feature (HTNF)Device
The Withings Hypertension Notification Feature (HTNF) is a software-only medical device (Software as a Medical Device, SaMD) that analyzes demographic, anthropometric, and physiological parameter data opportunistically collected by Withings connected smart scales to identify patterns suggestive of hypertension and provide a notification to the user.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Stage-Adjusted Sensitivity (Se) of the Withings HTNF AlgorithmTime frame: up to 7 years
- Stage-Adjusted Specificity (Sp) of the Withings HTNF AlgorithmTime frame: up to 7 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Withings SA
Issy-les-Moulineaux, Île-de-France Region, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.